FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 34 filers reported holding FENNEC PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 2.35 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,411 | -99.2% | 321 | -99.0% | 0.00% | -100.0% |
Q3 2021 | $298,000 | -63.7% | 31,728 | -71.8% | 0.00% | 0.0% |
Q2 2021 | $820,000 | -32.7% | 112,584 | -42.7% | 0.00% | -50.0% |
Q1 2021 | $1,219,000 | -24.8% | 196,477 | -9.9% | 0.00% | -33.3% |
Q4 2020 | $1,622,000 | +22.9% | 218,119 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $1,320,000 | +641.6% | 218,119 | +675.3% | 0.00% | – |
Q4 2018 | $178,000 | – | 28,132 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sonic GP LLC | 2,407,357 | $18,079,251 | 17.55% |
Solas Capital Management, LLC | 1,725,567 | $12,959,008 | 9.07% |
DG Capital Management, LLC | 1,143,099 | $8,584,673 | 4.70% |
HARBERT FUND ADVISORS, INC. | 466,869 | $3,506,186 | 2.56% |
AIGH Capital Management LLC | 373,526 | $2,805,180 | 1.33% |
Southpoint Capital Advisors LP | 4,077,214 | $30,619,877 | 0.68% |
APIS CAPITAL ADVISORS, LLC | 70,000 | $525,700 | 0.68% |
Worth Venture Partners, LLC | 92,636 | $695,696 | 0.41% |
Lion Point Capital, LP | 110,000 | $826,100 | 0.37% |
683 Capital Management, LLC | 300,000 | $2,253,000 | 0.18% |